Indivi

Indivi is an ISO 13485 and ISO 27001 certified TechBio company headquartered in Basel, Switzerland, dedicated to developing future sustainable functional biomarkers based on DHT tools that measure critical disability concepts in neuroscience therapeutic drug development trials, such as multiple sclerosis, Parkinson's disease and other alpha-synucleinopathies, Alzheimer's disease and related dementias, muscular dystrophy, and neuromuscular disorders.